Vivo Capital’s Curis CRIS Stock Holding History

Vivo Capital’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,884	Closed	-$12.2M	–	58
2021 Q3	$12.2M	Hold	3,884	–	–	0.55%	32
2021 Q2	$12.5M	Hold	3,884	–	–	0.54%	33
2021 Q1	$17.6M	Buy	3,884 +384	+11%	+$1.61M	0.62%	32
2020 Q4	$11.5M	Buy	+3,500	New	+$4.2M	0.51%	38

Other funds holding CRIS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Vivo Capital's CRIS Position: Q4 2021 in Review

Vivo Capital sold out of Curis (CRIS) in Q4 2021, closing a stake of 3,884 shares — an estimated $12.2M sold.

Vivo Capital first reported a position in CRIS in Q4 2020 and held it in 4 quarters. The position peaked at $17.6M in Q1 2021. 128 funds tracked by Wall St. Rank hold CRIS as of Q4 2021.

Vivo Capital reported no remaining Curis position as of Q4 2021 after selling out during the quarter.
Vivo Capital sold 3,884 Curis shares in Q4 2021, an estimated $12.2M.
Vivo Capital first reported a position in Curis in Q4 2020 and held it in 4 quarters.
Vivo Capital's Curis position peaked at $17.6M in Q1 2021.
128 funds tracked by Wall St. Rank held Curis as of Q4 2021.

Based on Vivo Capital's 13F filing for Q4 2021, filed 11 Feb 2022.